Literature DB >> 34877657

Erratum.

.   

Abstract

Entities:  

Year:  2021        PMID： 34877657      PMCID： PMC9050091          DOI： 10.1111/head.14109

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  1 in total

1.  Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double-Blind, Placebo-Controlled REGAIN, and Pooled EVOLVE-1 and EVOLVE-2 Studies.

Authors:  Todd A Smitherman; Gretchen E Tietjen; Kory Schuh; Vladimir Skljarevski; Sarah Lipsius; Deborah N D'Souza; Eric M Pearlman
Journal:  Headache       Date:  2020-10-16       Impact factor: 5.887
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.